Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2012; 18(35): 4944-4958
Published online Sep 21, 2012. doi: 10.3748/wjg.v18.i35.4944
Table 2 Grade 3 or 4 toxicity of selected clinical trials
Ref.InterventionVomitingDiarrheaNeutropeniaAnemiaThrombocytopenia
Louvet et al[15]Gem3.21.327.610.33.2
Gem + Oxaliplatin8.95.720.46.414.0
Poplin et al[16]Gem74331013
Gem + Oxaliplatin16622611
Heinemann et al[17]Gem5.94.7NR10.610.6
Gem + Cisplatin22.23.3NR13.34.4
Colucci et al[18]Gem20942
Gem + Cisplatin241862
Colucci et al[19]Gem< 11.513.7118.9
Gem + Cisplatin2.6< 124.74.815.3
Kulke et al[20]Gem24.1NR82.82043.1
Gem + Cisplatin29NR74.225.879
Gem + Irinotecan16.7NR41.78.323.3
Berlin et al[21]Gem8NR51011
Gem + 5-fluorouracil7NR71019
Herrmann et al[22,24]Gem421968
Gem + Capeitabine452384
Cunningham et al[23]Gem642266
Gem + Capeitabine6535411
Scheithauer et al[25]Gem007.602.5
Gem + Capeitabine051050
Costanzo et al[26]Gem00260
Gem + 5-fluorouracil20272
Abou-Alfa et al[27]Gem3.1< 114.67.64.4
Gem + Exatecan5.31.130.35.915.4
Stathopoulos et al[28]Gem1.42.815.74.20
Gem + Irinotecan1.63.226.655
Lima et al[29]Gem8.21.831.91314.2
Gem + Irinotecan13.918.537.616.219.6
Moore et al[38]GemNR< 127%NR11%
Gem + ErlotinibNR224%NR10%
Cutsem et al[39]Gem93301612
Gem + Tipifarnib74402015
Eckhardt et al[40]Gem9.3033.91115.3
Gem + Tipifarnib4035.512.116.1
Philip et al[37]Gem2.22.523.96.28.5
Gem + cetuximab6.62.823.39.76.6
Kindler et al[36]GemNRNR29812
Gem + BevacizumabNRNR33512
Kindler et al[35]Gem3.21.6< 1< 1< 1
Gem + Axitinib3.91.3000
Spano et al[41]Gem100331713
Gem + Axitinib6628820
Richards et al[33]Gem02.628.25.125.6
Gem + Enzastarin2.43.718.33.714.6
Bramhall et al[31]Gem14%NRNR7%NR
Gem + Marimastat6%NRNR3%NR
Richards et al[32]Gem93NR511
Gem + CA-99495NR132
Oettle et al[30]Gem3.70.712.82.96.2
Gem + Pemetrexed3.32.945.113.917.9